Anti-inflammatory agent 43

Catalog No. :
ACBMCM640
CAS No. :
2364631-99-0
Molecular Formula :
C34H42O22
Molecular Weight :
802.69

IUPAC Name:3-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-6-methoxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one

Anti-inflammatory agent 43 structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameAnti-inflammatory agent 43
IUPAC Name3-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-5-hydroxy-2-(4-hydroxyphenyl)-6-methoxy-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one
Molecular FormulaC34H42O22
Molecular Weight802.69
SMILESO=C1C(O[C@H]2[C@@H]([C@H]([C@@H]([C@@H](CO)O2)O)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](CO)O3)O)O)O)=C(C4=CC=C(O)C=C4)OC5=CC(O[C@H]6[C@@H]([C@H]([C@@H]([C@@H](CO)O6)O)O)O)=C(OC)C(O)=C15
InChI KeyWTMOPFXZPKSAKM-OCSFZBMJSA-N
Synonym6-Methoxykaempferol 3-O-β-D-glucopyranosyl-(1 →2)-β-D-glucopyranosyl-7-O-β-D- glucopyranoside;Anti-inflammatory agent 43
CAS No.2364631-99-0

Synthetic Route by SureRoute

1. ACBMCM640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBMCM640 route product structure diagram
    ACBMCM6402364631-99-0
Inquiry

2. ACBMCM640 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBMCM640 route product structure diagram
    ACBMCM6402364631-99-0
Inquiry

Comments (0)